Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?—A Study in Patients Treated with Methotrexate and an Anti-TNFα Agent

Background. Bone damage in rheumatoid arthritis (RA) and in psoriatic arthritis (PsA) includes an accelerated bone mineral density (BMD) reduction. The objective was to evaluate BMD variations of the metacarpophalangeal joints (MCPs) in patients starting treatment with methotrexate (MTX) or etanerce...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bertoldi, Ilaria, Filippou, Georgios, Scirè, Carlo Alberto, Picerno, Valentina, di Sabatino, Valentina, Adinolfi, Antonella, Pierguidi, Serena, Galeazzi, Mauro, Frediani, Bruno
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871921/
https://ncbi.nlm.nih.gov/pubmed/24381766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/708323
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items